Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imprime PGG with Bevacizumab and Chemotherapy in Advanced NSCLC
NCT00874107Phase 2Completed
- Sponsor
- HiberCell
- Start
- Jun 2009
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of odetiglucan in non-small cell lung cancer (NSCLC), sponsored by HiberCell. Started Jun 2009; status: completed.
02
Drugs
odetiglucan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00874107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874107.